Monday, June 8, 2026
ADVT 
National

Survey examines hesitancy in early vaccine rollout

Darpan News Desk The Canadian Press, 31 Aug, 2021 03:29 PM
  • Survey examines hesitancy in early vaccine rollout

A national survey suggests the vast majority of Canadians planned to get vaccinated against COVID-19 when the country's rollout began, but intentions were lower among certain demographics, including residents of Alberta and racialized communities.

The survey, led by researchers at Toronto's St. Michael's Hospital, was published online Tuesday in The Lancet Regional Health —Americas.

The survey asked more than 14,500 Canadians online between December 2020 and February 2021 if they intended to get vaccinated once they were eligible, with researchers identifying differences in participants by age, education, ethnicity, and home province.

Nine per cent of respondents overall said they did not intend to get vaccinated, with hesitancy highest in Alberta at 16 per cent, and Manitoba and Saskatchewan, both at 14 per cent.

Fifteen per cent of respondents who identified as Indigenous and 12 per cent of those identifying as racialized said they did not intend to get vaccinated.

Men were more hesitant than women overall — 11 per cent versus eight — and participants aged 40 to 59 had the lowest vaccination intention, with about 12 per cent reporting no intention to get vaccinated.

The survey suggested that education also factored into hesitancy, with 14 per cent of participants with a college education or less saying they did not intend to get vaccinated, compared to five per cent of respondents with a bachelor's degree or higher.

The study did not indicate whether intent translated into action, but researchers say they plan to answer that in the coming months.

They noted that 18 per cent of eligible Canadians had not yet received a COVID-19 vaccine dose by Aug. 27 — nearly twice the rate expected in the survey.

Researchers said the findings should encourage policymakers to target vaccine campaigns on the most reluctant groups, as well as those who said they planned to get a shot but did not.

The study was a collaboration between the Centre for Global Health Research at Unity Health Toronto, the University of Toronto and the Angus Reid Forum. Funding was provided by an unrestricted grant from Pfizer Global Medical Grants and Unity Health Toronto.

MORE National ARTICLES

Churches challenge B.C. COVID-19 health orders

Churches challenge B.C. COVID-19 health orders
Henry and the province have said they are confident the health orders are in accordance with the law, including the Charter of Rights and Freedoms.

Churches challenge B.C. COVID-19 health orders

1478 COVID19 cases over 3 days

1478 COVID19 cases over 3 days
With the additional supply from the newly approved AstraZeneca/Serum Institute of India viral vector vaccine, combined with setting the second dose interval at 16 weeks, everyone moves up the line, meaning more people will be vaccinated more quickly.

1478 COVID19 cases over 3 days

AstraZeneca's vaccine not for seniors: NACI

AstraZeneca's vaccine not for seniors: NACI
The AstraZeneca vaccine was authorized for use Friday on all adults, including seniors, but the National Advisory Committee on Immunization is concerned there is limited data on how well the vaccine will work in older populations.

AstraZeneca's vaccine not for seniors: NACI

B.C. to extend rent freeze through 2021

B.C. to extend rent freeze through 2021
The changes, if passed, will come into effect on July 1 and are in addition to earlier protections introduced in 2018.

B.C. to extend rent freeze through 2021

MPs to examine safety of travellers in quarantine

MPs to examine safety of travellers in quarantine
Liberal MP John McKay, the committee chairman, said Monday the hearing could take place this week but cautioned it would be a challenge to schedule witnesses in time.

MPs to examine safety of travellers in quarantine

How effective is the AstraZeneca vaccine?

How effective is the AstraZeneca vaccine?
Health Canada said Friday that real-world data from countries already using the product suggest it is safe and effective among older age groups.

How effective is the AstraZeneca vaccine?